title: Development of a standardized, comprehensive "ideal drug detail".
abstract: OBJECTIVE
  To develop a standardized, comprehensive ideal drug detail for use in face-to-face education about individual drugs.
  
  
  METHODS
  A random sample of 603 physicians and pharmacists was selected and stratified to include input from each of the following specialties: family practice, internal medicine, surgery, pediatrics, psychiatry, obstetrics/gynecology, geriatric medicine and clinical pharmacology. Thirty-one potential items were generated by the investigators from a preliminary survey of a local convenience sample of physicians and pharmacists. A modified Delphi consensus process was used in the large sample to determine which items should be included in the ideal drug detail. In each round of the Delphi process, respondents rated each item on a seven-point scale of importance and were then given feedback of the cumulative ratings for each item. Rounds were continued until consensus was obtained on all items.
  
  
  RESULTS
  The response rate to the first round was 55.3%; 85.5% of these respondents responded to the second round. Response rates varied between specialties from 44% to 70%. Attempts to contact nonresponders to measure potential nonrespondent bias were unsuccessful. Consensus was obtained on 19 items after the first round, and on the remaining 12 items after the second round. Four items were dropped because they were unimportant. There was variation in modal response between specialties on eight items.
  
  
  CONCLUSIONS
  Consensus was obtained among a sizable and interested sample of Canadian physicians and pharmacists on the items of information needed to prescribe a drug appropriately. Subsequent work will refine this list into a usable template to develop ideal drug details for specific drugs, to develop an assessment process to measure quality of information, and to assess the impact of this program on prescribing and patient outcomes.
authors.affiliation: Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba R3J 0L3, Canada. dgstrang@cc.umanitoba.ca
authors.forename: D G
authors.initials: DG
authors.lastname: Strang
authors.forename: M
authors.initials: M
authors.lastname: Gagnon
authors.forename: D W
authors.initials: DW
authors.lastname: Molloy
authors.forename: P
authors.initials: P
authors.lastname: Darzins
authors.forename: E
authors.initials: E
authors.lastname: Etchells
authors.forename: M
authors.initials: M
authors.lastname: Bédard
authors.forename: W
authors.initials: W
authors.lastname: Davidson
mesh_terms: D000328:Adult; D000368:Aged; D001291:Attitude of Health Personnel; D000075202:Contraindications; D003697:Delphi Technique; D004345:Drug Industry; D004346:Drug Information Services / Q000592:standards*; D004358:Drug Therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D008297:Male; D008511:Medicine; D008875:Middle Aged; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D013038:Specialization; D011795:Surveys and Questionnaires
chemical_list: D004364:Pharmaceutical Preparations